Evidence map›Paper›PMID 20000704›Full record

ArticleJournal of the American Chemical Society2010

An antibiotic-resistance enzyme from a deep-sea bacterium.

Marta Toth, Clyde Smith, Hilary Frase, Shahriar Mobashery, Sergei Vakulenko

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 66 citations in OpenAlex.

  1. Contributions of intra- and extracellular antibiotic degradation to collective [Formula: see text]-lactam survival.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. International journal of microbiology · 2024
    Article
  6. β-Lactams from the Ocean.Marine drugs · 2023
    Review
  7. Antibiotic resistance genes on the Qinghai-Tibet Plateau above an elevation of 5,000 m.Environmental science and pollution research international · 2022
    Article
  8. Article
  9. Review
  10. Inhibition of theACS infectious diseases · 2021
    Article
  11. Article
  12. Bactericidal assessment of nano-silver on emerging and re-emerging human pathogens.Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) · 2019
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Marta TothDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, USA.
Clyde Smith
Hilary Frase
Shahriar Mobashery
Sergei Vakulenko
Stanford Synchrotron Radiation Lightsource · USStanford University · USUniversity of Notre Dame · US

Funding

ZWITTERION SURFACTANT DDMAB FOR IMPROV STABIL OF PROTEINP41RR001209 · NCRR · STANFORD UNIVERSITY · PI GONZALEZ, ANA M · 1985 to 2011
$38.9M
NCRR NIH HHS P41 RR001209
6 · The paper itself

Abstract

We describe herein a highly proficient class A beta-lactamase OIH-1 from the bacterium Oceanobacillus iheyensis, whose habitat is the sediment at a depth of 1050 m in the Pacific Ocean. The OIH-1 structure was solved by molecular replacement and refined at 1.25 A resolution. OIH-1 has evolved to be an extremely halotolerant beta-lactamase capable of hydrolyzing its substrates in the presence of NaCl at saturating concentration. Not only is this the most highly halotolerant bacterial enzyme structure known to date, it is also the highest resolution halophilic protein structure yet determined. Evolution of OIH-1 in the salinity of the ocean has resulted in a molecular surface that is coated with acidic residues, a marked difference from beta-lactamases of terrestrial sources. OIH-1 is the first example of an antibiotic-resistance enzyme that has evolved in the depths of the ocean in isolation from clinical selection and gives us an extraordinary glimpse into protein evolution under extreme conditions. It represents evidence for the existence of a reservoir of antibiotic-resistance enzymes in nature among microbial populations from deep oceanic sources.

Indexed as

Bacillusbeta-LactamasesDrug Resistance, BacterialKineticsModels, Molecularbeta-Lactamases

Identifiers

PMID20000704
PMCPMC2826318
OpenAlexW2018249769

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.